nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

01.06.2015 | Original Article

The role of maternal screening in diagnosing congenital cytomegalovirus infections in highly immune populations

verfasst von: F. Şahiner, M. Honca, Y. Çekmez, A. Kubar, T. Honca, M. K. Fidanci, T. Purtuloğlu, M. Yapar

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Congenital cytomegalovirus (CMV) infection is the most important infectious cause of central nervous system disease and hearing loss in children.

Aims

In this study, we aimed to investigate the role of maternal screening in early diagnosis of congenital infection in highly immune populations.

Methods

A total of 163 women were included in the study; 103 of the subjects were pregnant and were at full term. The other 60 women were not pregnant, and all were healthy.

Results

CMV IgG seropositivity among the pregnant and control groups was found to be 98.1 % (101/103) and 98.3 % (59/60), respectively, and high IgG avidity was found in all women who had IgG positivity. We did not find any primary CMV infection in the two groups. The recurrent infection rate was found to be 5.82 % in the pregnant group and 3.33 % in the control group. There were no significant differences between the pregnant and control women in terms of CMV excretion in urine samples (4.85 vs. 3.33 %, respectively; P = 1.000) or CMV-DNA presence in serum samples (1.94 vs. 0.0 %, respectively; P = 0.532). The presence of symptomatic infection was not observed in any of the 104 babies born from the 103 pregnancies.

Conclusions

According to our results, a maternal screening-based approach would be useful for only a very small group that is at risk of primary infection. Considering the cost of the scan, a routine maternal-based screening program is unadvisable in developing societies, but it is necessary for studies of different cohort groups and infectious diseases.

Mocarski ES, Pass RF (2008) Human cytomegalovirus: general features. In: Mahy BWJ, Van Regenmortel MHV (eds) Encyclopedia of virology, 3rd edn. Academic Press, Oxford, pp 474–485CrossRef

Preston CM (2008) Herpesviruses: latency. In: Mahy BWJ, Van Regenmortel MHV (eds) Encyclopedia of virology, 3rd edn. Academic Press, Oxford, pp 436–442CrossRef

Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17(4):253–276CrossRefPubMed

Cannon MJ, Hyde TB, Schmid DS (2011) Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 21(4):240–255CrossRefPubMed

Boppana SB (2006) Cytomegalovirus. In: Hutto C (ed) Congenital and perinatal infections. Humana Press Inc., Totowa, pp 73–86CrossRef

de Graan-Hentzen YC, Gratama JW, Mudde GC et al (1989) Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 29:757–760CrossRefPubMed

Schoenfisch AL, Dollard SC, Amin M et al (2011) Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women. J Med Microbiol 60(Pt 6):768–774CrossRefPubMed

Pereira L, Maidji E, McDonagh S, Tabata T (2005) Insights into viral transmission at the uterine-placental interface. Trends Microbiol 13(4):164–174CrossRefPubMed

Stagno S, Pass RF, Cloud G et al (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256(14):1904–1908CrossRefPubMed

10.

Ahlfors K, Ivarsson SA, Harris S et al (1984) Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infections. Scand J Infect Dis 16(2):129–137CrossRefPubMed

11.

Stagno S, Reynolds DW, Huang ES, Thames SC, Smith RJ, Alford CA (1977) Congenital cytomegalovirus infection: occurrence in an immune population. N Engl J Med 296(22):1254–1258CrossRefPubMed

12.

Morris DJ, Sims D, Chiswick M, Das VK, Newton VE (1994) Symptomatic congenital cytomegalovirus infection after maternal recurrent infection. Pediatr Infect Dis J 13(1):61–64CrossRefPubMed

13.

Picone O, Vauloup-Fellous C, Cordier AG et al (2013) A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 33(8):751–758CrossRefPubMed

14.

Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP (2000) Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 137(1):90–95CrossRefPubMed

15.

Sambrook J, Fritsch EF, Maniatis T (1989) Isolation of DNA from mammalian cells. In: Sambrook J, Fritsch EF, Maniatis T (eds) Molecular cloning: a laboratory manual (Vol 1), 2nd edn. Cold Spring Harbor Laboratory Press, New York, pp 9.16–9.19

16.

Kubar A, Saygun I, Yapar M, Ozdemir A, Slots J (2004) Real-time PCR quantification of cytomegalovirus in aggressive periodontitis lesions using TaqMan technology. J Periodontal Res 39(2):81–86CrossRefPubMed

17.

Kubar A, Saygun I, Özdemir A, Yapar M, Slots J (2005) Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions. J Periodont Res 40:97–104CrossRefPubMed

18.

Yapar M, Aydogan H, Pahsa A et al (2005) Rapid and quantitative detection of Crimean-Congo haemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn J Infect Dis 58:358–362PubMed

19.

Sahiner F, Gumral R, Sener K et al (2012) Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR. Mikrobiyol Bul 46(4):624–636PubMed

20.

Ludwig A, Hengel H (2009) Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill 14(9):26–32PubMed

21.

Naessens A, Casteels A, Decatte L, Foulon W (2005) A serologic strategy for detecting neonates at risk for congenital cytomegalovirus infection. J Pediatr 146(2):194–197CrossRefPubMed

22.

Grangeot-Keros L, Simon B, Audibert F, Vial M (1998) Should we routinely screen for cytomegalovirus antibody during pregnancy? Intervirology 41(4–5):158–162CrossRefPubMed

23.

Lazzarotto T, Varani S, Spezzacatena P et al (1998) Delayed acquisition of high-avidity anticytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients. J Infect Dis 178(4):1145–1149CrossRefPubMed

24.

Lazzarotto T, Spezzacatena P, Varani S et al (1999) Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin Diagn Lab Immunol 6(1):127–129PubMedCentralPubMed

25.

Ataman S, Colak D, Gunseren F et al (2007) Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey. Mikrobiyol Bul 41(4):545–555PubMed

26.

Satılmış A, Güra A, Ongun H, Mendilcioğlu I, Çolak D, Oygür N (2007) CMV seroconversion in pregnants and the incidence of congenital CMV infection. Turk J Pediatr 49(1):30–36PubMed

27.

Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A (2007) Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand J Infect Dis 39(3):231–234CrossRefPubMed

28.

Griffiths PD, Baboonian C, Rutter D, Peckham C (1991) Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol 98(2):135–140CrossRefPubMed

29.

Yow MD, Williamson DW, Leeds LJ et al (1988) Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol 158(5):1189–1195CrossRefPubMed

30.

Shen CY, Chang SF, Yen MS, Ng HT, Huang ES, Wu CW (1993) Cytomegalovirus excretion in pregnant and nonpregnant women. J Clin Microbiol 31(6):1635–1636PubMedCentralPubMed

31.

Stagno S, Reynolds D, Tsiantos A et al (1975) Cervical cytomegalovirus excretion in pregnant and nonpregnant women: suppression in early gestation. J Infect Dis 131(5):522–527CrossRefPubMed

32.

Collier AC, Handsfield HH, Ashley R et al (1995) Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis 171(1):33–38CrossRefPubMed

33.

Pass RF, Stagno S, Dworsky ME, Smith RJ, Alford CA (1982) Excretion of cytomegalovirus in mothers: observation after delivery of congenitally infected and normal infants. J Infect Dis 146(1):1–6CrossRefPubMed

34.

Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5):355–363CrossRefPubMed

35.

Stagno S, Pass RF, Dworsky ME, Alford CA (1983) Congenital and perinatal cytomegalovirus infections. Semin Perinatol 7(1):31–42PubMed

36.

Fowler KB, Stagno S, Pass RF (2003) Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289(8):1008–1011CrossRefPubMed

Titel: The role of maternal screening in diagnosing congenital cytomegalovirus infections in highly immune populations
verfasst von: F. Şahiner
M. Honca
Y. Çekmez
A. Kubar
T. Honca
M. K. Fidanci
T. Purtuloğlu
M. Yapar
Publikationsdatum: 01.06.2015
Verlag: Springer London
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 2/2015
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-014-1149-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Radiation safety knowledge and practices among Irish orthopaedic trainees

Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery

Allergy in Irish adults: a survey of referrals and outcomes at a major centre

Efficacy of uvulopalatopharyngoplasty combined with oral appliance in treatment of obstructive sleep apnea–hypopnea syndrome

Venous thromboembolism prophylaxis guideline compliance: a pilot study of augmented medication charts